Skip to main content
Top
Published in: Annals of Surgical Oncology 1/2022

01-01-2022 | Breast Cancer | Global Health Services Research

Racial and Socioeconomic Disparities in Breast Cancer Outcomes within the AJCC Pathologic Prognostic Staging System

Authors: Olga Kantor, MD MS, Monica L. Wang, ScD MS, Kimberly Bertrand, MPH ScD, Lori Pierce, MD, Rachel A. Freedman, MD MPH, Mariana Chavez-MacGregor, MD, Tari A. King, MD, Elizabeth A. Mittendorf, MD PhD

Published in: Annals of Surgical Oncology | Issue 1/2022

Login to get access

Abstract

Background

Non-Hispanic black (NHB) women and those of lower socioeconomic status (SES) have inferior breast cancer outcomes compared with non-Hispanic white (NHW) women and those of higher SES. We examined racial and SES disparities in breast cancer survival within the AJCC 8th edition pathologic prognostic staging system.

Methods

Using the Surveillance, Epidemiology and End Results Program, we identified patients diagnosed with invasive breast cancer from 2010 to 2015, with follow-up through 2016. Census tract-level SES (cSES) data were available as a composite index and analyzed in quintiles. Cox proportional-hazards survival analyses adjusted for age, race, cSES, insurance, marital status, histology, pathologic prognostic stage, and treatment were used to estimate disease-specific survival (DSS).

Results

A total of 259,852 patients were included: 176,369 (67.9%) NHW; 28,510 (11.0%) NHB; 29,737 (11.4%) Hispanic; and 22,887 (8.8%) Asian. NHB race and lower cSES were associated with increased incidence of triple-negative disease compared with NHW (< 0.01). NHB race, lower cSES, public insurance, lower education, and increased poverty were associated with lower DSS. Survival analyses adjusting for cSES, tumor, and treatment characteristics demonstrated that NHB patients had inferior DSS within each AJCC pathologic prognostic stage (hazard ratio [HR] 1.25, 95% confidence interval [CI] 1.20–1.30) compared with NHW patients. Fully adjusted models also showed patients residing in lower SES counties had inferior DSS.

Conclusions

Racial and cSES disparities in breast cancer-specific mortality were evident across all stages, even within the pathologic prognostic staging system which incorporates tumor biology. Future efforts should assess the biological, behavioral, social, and environmental determinants that underlie racial and SES inequities in outcomes.
Appendix
Available only for authorised users
Literature
2.
go back to reference Smith-Graziani D, Lei X, Giordano SH, Zhao H, Karuturi M, Chavez-MacGregor M. Delayed initiation of adjuvant chemotherapy in older women with breast cancer. Cancer Med. 2020;9(19):6961–71.CrossRef Smith-Graziani D, Lei X, Giordano SH, Zhao H, Karuturi M, Chavez-MacGregor M. Delayed initiation of adjuvant chemotherapy in older women with breast cancer. Cancer Med. 2020;9(19):6961–71.CrossRef
3.
go back to reference Gorin SS, Heck JE, Cheng B, Smith SJ. Delays in breast cancer diagnosis and treatment by racial/ethnic group. Arch Intern Med. 2006;166(20):2244–52.CrossRef Gorin SS, Heck JE, Cheng B, Smith SJ. Delays in breast cancer diagnosis and treatment by racial/ethnic group. Arch Intern Med. 2006;166(20):2244–52.CrossRef
4.
go back to reference Ellis L, Canchola AJ, Spiegel D, Ladabaum U, Haile R, Gomez SL. Racial and ethnic disparities in cancer survival: the contribution of tumor, sociodemographic, institutional, and neighborhood characteristics. J Clin Oncol. 2018;36(1):25–33.CrossRef Ellis L, Canchola AJ, Spiegel D, Ladabaum U, Haile R, Gomez SL. Racial and ethnic disparities in cancer survival: the contribution of tumor, sociodemographic, institutional, and neighborhood characteristics. J Clin Oncol. 2018;36(1):25–33.CrossRef
5.
go back to reference Jemal A, Robbins AS, Lin CC, et al. Factors that contributed to black-white disparities in survival among nonelderly women with breast cancer between 2004 and 2013. J Clin Oncol. 2018;36(1):14–24.CrossRef Jemal A, Robbins AS, Lin CC, et al. Factors that contributed to black-white disparities in survival among nonelderly women with breast cancer between 2004 and 2013. J Clin Oncol. 2018;36(1):14–24.CrossRef
6.
go back to reference Wallner LP, Griggs JJ. Advancing the science of cancer health disparities research. J Clin Oncol. 2018;36(1):1–3.CrossRef Wallner LP, Griggs JJ. Advancing the science of cancer health disparities research. J Clin Oncol. 2018;36(1):1–3.CrossRef
7.
go back to reference Carey LA, Perou CM, Livasy CA, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA. 2006;295(21):2492–502.CrossRef Carey LA, Perou CM, Livasy CA, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA. 2006;295(21):2492–502.CrossRef
8.
go back to reference Albain KS, Unger JM, Crowley JJ, Coltman CA Jr, Hershman DL. Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group. J Natl Cancer Inst. 2009;101(14):984–92.CrossRef Albain KS, Unger JM, Crowley JJ, Coltman CA Jr, Hershman DL. Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group. J Natl Cancer Inst. 2009;101(14):984–92.CrossRef
9.
go back to reference Linnenbringer E, Gehlert S, Geronimus AT. Black-white disparities in breast cancer subtype: the intersection of socially patterned stress and genetic expression. AIMS Public Health. 2017;4(5):526–56.CrossRef Linnenbringer E, Gehlert S, Geronimus AT. Black-white disparities in breast cancer subtype: the intersection of socially patterned stress and genetic expression. AIMS Public Health. 2017;4(5):526–56.CrossRef
10.
go back to reference Smith CJ, Minas TZ, Ambs S. Analysis of tumor biology to advance cancer health disparity research. Am J Pathol. 2018;188(2):304–16.CrossRef Smith CJ, Minas TZ, Ambs S. Analysis of tumor biology to advance cancer health disparity research. Am J Pathol. 2018;188(2):304–16.CrossRef
11.
go back to reference Newman LA. Disparities in breast cancer and african ancestry: a global perspective. Breast J. 2015;21(2):133–9.CrossRef Newman LA. Disparities in breast cancer and african ancestry: a global perspective. Breast J. 2015;21(2):133–9.CrossRef
12.
go back to reference Churpek JE, Walsh T, Zheng Y, et al. Inherited predisposition to breast cancer among African American women. Breast Cancer Res Treat. 2015;149(1):31–9.CrossRef Churpek JE, Walsh T, Zheng Y, et al. Inherited predisposition to breast cancer among African American women. Breast Cancer Res Treat. 2015;149(1):31–9.CrossRef
13.
go back to reference Poulson MR, Beaulieu-Jones BR, Kenzik KM, et al. Residential racial segregation and disparities in breast cancer presentation, treatment, and survival. Ann Surg. 2021;273(1):3–9.CrossRef Poulson MR, Beaulieu-Jones BR, Kenzik KM, et al. Residential racial segregation and disparities in breast cancer presentation, treatment, and survival. Ann Surg. 2021;273(1):3–9.CrossRef
14.
go back to reference Coughlin SS. Social determinants of breast cancer risk, stage, and survival. Breast Cancer Res Treat. 2019;177(3):537–48.CrossRef Coughlin SS. Social determinants of breast cancer risk, stage, and survival. Breast Cancer Res Treat. 2019;177(3):537–48.CrossRef
15.
go back to reference Collin LJ, Gaglioti AH, Beyer KM, et al. Neighborhood-level redlining and lending bias are associated with breast cancer mortality in a large and diverse metropolitan area. Cancer Epidemiol Biomarkers Prev. 2021;30(1):53–60.CrossRef Collin LJ, Gaglioti AH, Beyer KM, et al. Neighborhood-level redlining and lending bias are associated with breast cancer mortality in a large and diverse metropolitan area. Cancer Epidemiol Biomarkers Prev. 2021;30(1):53–60.CrossRef
16.
go back to reference American Joint Committee on Cancer. AJCC Cancer Staging Manual. 8th edn. Chicago: Springer; 2017. American Joint Committee on Cancer. AJCC Cancer Staging Manual. 8th edn. Chicago: Springer; 2017.
17.
go back to reference Newman LA. Breast cancer disparities: high-risk breast cancer and African ancestry. Surg Oncol Clin N Am. 2014;23(3):579–92.CrossRef Newman LA. Breast cancer disparities: high-risk breast cancer and African ancestry. Surg Oncol Clin N Am. 2014;23(3):579–92.CrossRef
18.
go back to reference Linnenbringer E, Geronimus AT, Davis KL, Bound J, Ellis L, Gomez SL. Associations between breast cancer subtype and neighborhood socioeconomic and racial composition among Black and White women. Breast Cancer Res Treat. 2020;180(2):437–47.CrossRef Linnenbringer E, Geronimus AT, Davis KL, Bound J, Ellis L, Gomez SL. Associations between breast cancer subtype and neighborhood socioeconomic and racial composition among Black and White women. Breast Cancer Res Treat. 2020;180(2):437–47.CrossRef
19.
go back to reference Yu M, Tatalovich Z, Gibson JT, Cronin KA. Using a composite index of socioeconomic status to investigate health disparities while protecting the confidentiality of cancer registry data. Cancer Causes Control. 2014;25(1):81–92.CrossRef Yu M, Tatalovich Z, Gibson JT, Cronin KA. Using a composite index of socioeconomic status to investigate health disparities while protecting the confidentiality of cancer registry data. Cancer Causes Control. 2014;25(1):81–92.CrossRef
20.
go back to reference Yost K, Perkins C, Cohen R, Morris C, Wright W. Socioeconomic status and breast cancer incidence in California for different race/ethnic groups. Cancer Causes Control. 2001;12(8):703–11.CrossRef Yost K, Perkins C, Cohen R, Morris C, Wright W. Socioeconomic status and breast cancer incidence in California for different race/ethnic groups. Cancer Causes Control. 2001;12(8):703–11.CrossRef
22.
go back to reference Gorey KM, Luginaah IN, Schwartz KL, et al. Increased racial differences on breast cancer care and survival in America: historical evidence consistent with a health insurance hypothesis, 1975–2001. Breast Cancer Res Treat. 2009;113(3):595–600.CrossRef Gorey KM, Luginaah IN, Schwartz KL, et al. Increased racial differences on breast cancer care and survival in America: historical evidence consistent with a health insurance hypothesis, 1975–2001. Breast Cancer Res Treat. 2009;113(3):595–600.CrossRef
23.
go back to reference Miller JW, Smith JL, Ryerson AB, Tucker TC, Allemani C. Disparities in breast cancer survival in the United States (2001–2009): findings from the CONCORD-2 study. Cancer. 2017;123(Suppl 24):5100–18.CrossRef Miller JW, Smith JL, Ryerson AB, Tucker TC, Allemani C. Disparities in breast cancer survival in the United States (2001–2009): findings from the CONCORD-2 study. Cancer. 2017;123(Suppl 24):5100–18.CrossRef
24.
go back to reference Hortobagyi GN, Edge SB, Giuliano A. New and important changes in the TNM staging system for breast cancer. Am Soc Clin Oncol Educ Book. 2018;38:457–67.CrossRef Hortobagyi GN, Edge SB, Giuliano A. New and important changes in the TNM staging system for breast cancer. Am Soc Clin Oncol Educ Book. 2018;38:457–67.CrossRef
25.
go back to reference Plichta JK, Ren Y, Thomas SM, et al. Implications for breast cancer restaging based on the 8th edition AJCC staging manual. Ann Surg. 2020;271(1):169–76.CrossRef Plichta JK, Ren Y, Thomas SM, et al. Implications for breast cancer restaging based on the 8th edition AJCC staging manual. Ann Surg. 2020;271(1):169–76.CrossRef
26.
go back to reference Kantor O, Niu J, Zhao H, et al. Comparative analysis of proposed strategies for incorporating biologic factors into breast cancer staging. Ann Surg Oncol. 2020;27(7):2229–37.CrossRef Kantor O, Niu J, Zhao H, et al. Comparative analysis of proposed strategies for incorporating biologic factors into breast cancer staging. Ann Surg Oncol. 2020;27(7):2229–37.CrossRef
27.
go back to reference Katz SJ, Hofer TP. Socioeconomic disparities in preventive care persist despite universal coverage. Breast and cervical cancer screening in Ontario and the United States. JAMA. 1994;272(7):530–4.CrossRef Katz SJ, Hofer TP. Socioeconomic disparities in preventive care persist despite universal coverage. Breast and cervical cancer screening in Ontario and the United States. JAMA. 1994;272(7):530–4.CrossRef
28.
go back to reference Griggs JJ, Sorbero ME, Stark AT, Heininger SE, Dick AW. Racial disparity in the dose and dose intensity of breast cancer adjuvant chemotherapy. Breast Cancer Res Treat. 2003;81(1):21–31.CrossRef Griggs JJ, Sorbero ME, Stark AT, Heininger SE, Dick AW. Racial disparity in the dose and dose intensity of breast cancer adjuvant chemotherapy. Breast Cancer Res Treat. 2003;81(1):21–31.CrossRef
29.
go back to reference Griggs JJ, Culakova E, Sorbero ME, et al. Effect of patient socioeconomic status and body mass index on the quality of breast cancer adjuvant chemotherapy. J Clin Oncol. 2007;25(3):277–84.CrossRef Griggs JJ, Culakova E, Sorbero ME, et al. Effect of patient socioeconomic status and body mass index on the quality of breast cancer adjuvant chemotherapy. J Clin Oncol. 2007;25(3):277–84.CrossRef
30.
go back to reference Freedman RA, Hughes ME, Ottesen RA, et al. Use of adjuvant trastuzumab in women with human epidermal growth factor receptor 2 (HER2)-positive breast cancer by race/ethnicity and education within the National Comprehensive Cancer Network. Cancer. 2013;119(4):839–46.CrossRef Freedman RA, Hughes ME, Ottesen RA, et al. Use of adjuvant trastuzumab in women with human epidermal growth factor receptor 2 (HER2)-positive breast cancer by race/ethnicity and education within the National Comprehensive Cancer Network. Cancer. 2013;119(4):839–46.CrossRef
31.
go back to reference Hershman DL, Tsui J, Wright JD, Coromilas EJ, Tsai WY, Neugut AI. Household net worth, racial disparities, and hormonal therapy adherence among women with early-stage breast cancer. J Clin Oncol. 2015;33(9):1053–9.CrossRef Hershman DL, Tsui J, Wright JD, Coromilas EJ, Tsai WY, Neugut AI. Household net worth, racial disparities, and hormonal therapy adherence among women with early-stage breast cancer. J Clin Oncol. 2015;33(9):1053–9.CrossRef
32.
go back to reference Acheampong T, Kehm RD, Terry MB, Argov EL, Tehranifar P. Incidence trends of breast cancer molecular subtypes by age and race/ethnicity in the US From 2010 to 2016. JAMA Netw Open. 2020;3(8):e2013226.CrossRef Acheampong T, Kehm RD, Terry MB, Argov EL, Tehranifar P. Incidence trends of breast cancer molecular subtypes by age and race/ethnicity in the US From 2010 to 2016. JAMA Netw Open. 2020;3(8):e2013226.CrossRef
33.
go back to reference Quan L, Hong CC, Zirpoli G, et al. Variants of estrogen-related genes and breast cancer risk in European and African American women. Endocr Relat Cancer. 2014;21(6):853–64.CrossRef Quan L, Hong CC, Zirpoli G, et al. Variants of estrogen-related genes and breast cancer risk in European and African American women. Endocr Relat Cancer. 2014;21(6):853–64.CrossRef
34.
go back to reference Huo D, Hu H, Rhie SK, et al. Comparison of breast cancer molecular features and survival by African and European Ancestry in the Cancer Genome Atlas. JAMA Oncol. 2017;3(12):1654–62.CrossRef Huo D, Hu H, Rhie SK, et al. Comparison of breast cancer molecular features and survival by African and European Ancestry in the Cancer Genome Atlas. JAMA Oncol. 2017;3(12):1654–62.CrossRef
Metadata
Title
Racial and Socioeconomic Disparities in Breast Cancer Outcomes within the AJCC Pathologic Prognostic Staging System
Authors
Olga Kantor, MD MS
Monica L. Wang, ScD MS
Kimberly Bertrand, MPH ScD
Lori Pierce, MD
Rachel A. Freedman, MD MPH
Mariana Chavez-MacGregor, MD
Tari A. King, MD
Elizabeth A. Mittendorf, MD PhD
Publication date
01-01-2022
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 1/2022
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-021-10527-8

Other articles of this Issue 1/2022

Annals of Surgical Oncology 1/2022 Go to the issue